Chemours (CC) Tops Q4 EPS by 14c

Chemours (NYSE: CC) reported Q4 EPS of $0.56, $0.14 better than the analyst estimate of $0.42. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.35 billion.

GUIDANCE:

Chemours sees FY2020 EPS of $2.60-$3.55, versus the consensus of $3.16.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Intercontinental Exchange (ICE) PT Lowered to $208 at Raymond James, 'we view the risk/reward as attractive'
• Morgan Stanley Resumes Urban Outfitters, Inc. (URBN) at Overweight